O'Shaughnessy Asset Management’s Acer Therapeutics Inc ACER Stock Holding History

O'Shaughnessy Asset Management’s Portfolio ACER Stock Details ACER Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-225	Closed	-$1K	–	2658
2021 Q3	$1K	Hold	225	–	–	﹤0.01%	2677
2021 Q2	$1K	Hold	225	–	–	﹤0.01%	2526
2021 Q1	$1K	Hold	225	–	–	﹤0.01%	2318
2020 Q4	$1K	Hold	225	–	–	﹤0.01%	2025
2020 Q3	$1K	Hold	225	–	–	﹤0.01%	1829
2020 Q2	$1K	Buy	+225	New	+$635	﹤0.01%	1686
2020 Q1	–	Sell	-3,593	Closed	-$14K	–	1907
2019 Q4	$14K	Buy	+3,593	New	+$12.2K	﹤0.01%	1233

Other funds holding ACER

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

O'Shaughnessy Asset Management's ACER Position: Q4 2021 in Review

O'Shaughnessy Asset Management sold out of Acer Therapeutics Inc (ACER) in Q4 2021, closing a stake of 225 shares — an estimated $1K sold.

O'Shaughnessy Asset Management first reported a position in ACER in Q4 2019 and held it in 7 quarters. The position peaked at $14K in Q4 2019. 24 funds tracked by Wall St. Rank hold ACER as of Q4 2021.

O'Shaughnessy Asset Management reported no remaining Acer Therapeutics Inc position as of Q4 2021 after selling out during the quarter.
O'Shaughnessy Asset Management sold 225 Acer Therapeutics Inc shares in Q4 2021, an estimated $1K.
O'Shaughnessy Asset Management first reported a position in Acer Therapeutics Inc in Q4 2019 and held it in 7 quarters.
O'Shaughnessy Asset Management's Acer Therapeutics Inc position peaked at $14K in Q4 2019.
24 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q4 2021.

Based on O'Shaughnessy Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.